| 14774-4 |
Haloperidol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Haloperidol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14774-4 |
|
|
|
|
Both |
|
|
|
0 |
Haloperidol SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Haldol; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serenace; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14775-1 |
Hemoglobin |
MCnc |
BldA |
Pt |
Qn |
Oximetry |
|
ACTIVE |
Hemoglobin [Mass/volume] in Arterial blood by Oximetry |
|
MIN |
DefinitionDescription |
|
|
g/L |
|
|
|
|
|
|
HEM/BC |
|
14775-1 |
|
Oximetry |
|
|
Both |
|
|
|
0 |
Hgb BldA Oximetry-mCnc |
|
|
|
Y |
|
ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Level; Lung; Mass Concentration; Point in time; Pulmonary; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory |
2.73 |
1.0k |
|
|
|
|
|
|
|
g/dL |
|
|
|
0 |
| 14776-9 |
Heptacarboxylate |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Heptacarboxylate [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14776-9 |
|
|
|
|
Both |
|
|
|
0 |
Heptacarboxylate Plas-sCnc |
|
|
|
Y |
|
Chemistry; Heptacarbox; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14777-7 |
Heptacarboxylate |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Heptacarboxylate [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14777-7 |
|
|
|
|
Both |
|
|
|
0 |
Heptacarboxylate Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Heptacarbox; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14778-5 |
Heptacarboxylate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Heptacarboxylate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14778-5 |
|
|
|
|
Both |
|
|
|
0 |
Heptacarboxylate Ur-sCnc |
|
|
|
Y |
|
Chemistry; Heptacarbox; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14779-3 |
Hexacarboxylate |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
Hexacarboxylate [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14779-3 |
|
|
|
|
Both |
|
|
|
0 |
Hexacarboxylate Plas-sCnc |
|
|
|
Y |
|
Chemistry; Hexacarbox; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 1478-7 |
Follitropin^pre dose gonadotropin releasing hormone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Follitropin [Mass/volume] in Serum or Plasma --pre dose gonadotropin releasing hormone |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
1478-7 |
|
|
|
|
Observation |
|
|
|
0 |
FSH pre GnRH SerPl-mCnc |
|
|
|
Y |
|
Before; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; Pl; Plasma; Plsm; Point in time; pre GnRH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 14780-1 |
Hexacarboxylate |
SCnc |
Stool |
Pt |
Qn |
|
|
ACTIVE |
Hexacarboxylate [Moles/volume] in Stool |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14780-1 |
|
|
|
|
Both |
|
|
|
0 |
Hexacarboxylate Stl-sCnc |
|
|
|
Y |
|
Bowel movement; Chemistry; Faecal; Faeces; Fecal; Feces; Hexacarbox; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Stl; Stool = Fecal; Substance Concentration |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14781-9 |
Hexacarboxylate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Hexacarboxylate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14781-9 |
|
|
|
|
Both |
|
|
|
0 |
Hexacarboxylate Ur-sCnc |
|
|
|
Y |
|
Chemistry; Hexacarbox; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14782-7 |
Homovanillate |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Homovanillate [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
14782-7 |
|
|
|
|
Both |
|
|
|
0 |
HVA Ur-sCnc |
|
|
|
Y |
|
3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillic acid; HVA; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; Tumor marker; UA; UR; Urn |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14783-5 |
Homovanillate |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Homovanillate [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/d |
|
|
|
|
|
|
CHEM |
|
14783-5 |
|
|
|
|
Both |
|
|
|
0 |
HVA 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; 3-methoxy-4-hydroxy-phenylacetic acid; Chemistry; Homovanilic; Homovanillic acid; HVA; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; Tumor marker; UA; UR; Urn |
2.4 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 14784-3 |
Hydroxyproline.free |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydroxyproline Free [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
14784-3 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline Free 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; FR; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Non-protein bound; Ohpro; OH-Proline; OH-Proline Free; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 14785-0 |
Hydroxyproline |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Hydroxyproline [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
umol/24 H |
|
|
|
|
|
|
CHEM |
|
14785-0 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Ohpro; OH-Proline; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/(24.h) |
|
|
|
0 |
| 14786-8 |
Arthropod identified |
Prid |
XXX |
Pt |
Nom |
Micro/Micro |
|
DEPRECATED |
Deprecated Arthropod identified in Unspecified specimen |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14786-8 |
|
Micro/Micro |
|
|
|
|
|
|
0 |
Deprecated Insect XXX |
|
|
|
|
|
Arthropods; Fleas; Fly; ID; Identity or presence; Infectious Disease; InfectiousDisease; Insect; Isolated; Lice; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Tick; Ticks; To be specified in another part of the message; Unspecified |
2.69 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 14787-6 |
Arthropod |
Prid |
XXX |
Pt |
Nom |
Perm mount |
|
ACTIVE |
Arthropod identified in Specimen by Permanent mount |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14787-6 |
|
Perm mount |
|
|
Both |
|
|
|
0 |
Insect Spec Perm Mount |
|
|
|
|
|
Arthropods; Fleas; Fly; ID; Identity or presence; Infectious Disease; InfectiousDisease; Insect; Lice; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Tick; Ticks; To be specified in another part of the message; Unspecified |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 14788-4 |
Helminth+Arthropod |
Prid |
XXX |
Pt |
Nom |
Rearing/Culture |
|
ACTIVE |
Helminth+Arthropod identified in Specimen by Rearing/Culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14788-4 |
|
Rearing/Culture |
|
|
Both |
|
|
|
0 |
Worm+Insect Spec Rearing/Cult |
|
|
|
|
|
Arthropods; C&S; Cult; Cultures; Fleas; Fly; Helminths; ID; Identity or presence; Infectious Disease; InfectiousDisease; Insect; Lice; Maggot; Maggots; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; Tick; Ticks; To be specified in another part of the message; Unspecified; Worm; Worm+Insect; Worms |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 14789-2 |
Helminth |
Prid |
XXX |
Pt |
Nom |
Macro/Micro ID |
|
ACTIVE |
Helminth identified in Specimen by Macro/micro identification |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14789-2 |
|
Macro/Micro ID |
|
|
Both |
|
|
|
0 |
Worm Spec Macro/micro Id |
|
|
|
|
|
Helminths; ID; Identifier; Identity or presence; Infectious Disease; InfectiousDisease; Intradermal; Maggot; Maggots; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Worm; Worms |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 1479-5 |
Galactose^1.5H post 40 g galactose PO |
MCnc |
Bld |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in Blood --1.5 hours post 40 g galactose PO |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1479-5 |
|
|
|
|
Observation |
|
|
|
0 |
Galactose 4.5h p 40 g Gal PO Bld-mCnc |
|
|
|
Y |
|
1 1/2 hours; 1 1/2 HR; 1.5Hr; 4.5h p 40 g Gal PO; 90 min; 90 minutes; 90M; 90min; After; Blood; Cerebrose; CHEMISTRY.CHALLENGE TESTING; Galactose tolerance test; Level; Mass concentration; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.4 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14790-0 |
Helminth |
Prid |
XXX |
Pt |
Nom |
Perm mount |
|
ACTIVE |
Helminth identified in Specimen by Permanent mount |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
14790-0 |
|
Perm mount |
|
|
Both |
|
|
|
0 |
Worm Spec Perm Mount |
|
|
|
|
|
Helminths; ID; Identity or presence; Infectious Disease; InfectiousDisease; Maggot; Maggots; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified; Worm; Worms |
2.79 |
1.0k |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; |
0 |
| 14791-8 |
Imipramine+Desipramine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
Imipramine+Desipramine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14791-8 |
|
|
|
|
Both |
|
|
|
0 |
Imipramine+Desipr Gast Ql |
|
|
|
|
|
Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Imipra; Imipramine metabolite; Norpramin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tofranil |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14792-6 |
Imipramine+Desipramine |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Imipramine+Desipramine [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14792-6 |
|
|
|
|
Both |
|
|
|
0 |
Imipramine+Desipr SerPl Ql |
|
|
|
|
|
Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipra; Imipramine metabolite; Norpramin; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tofranil |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14793-4 |
Imipramine+Desipramine |
PrThr |
Urine |
Pt |
Ord |
|
|
ACTIVE |
Imipramine+Desipramine [Presence] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14793-4 |
|
|
|
|
Both |
|
|
|
0 |
Imipramine+Desipr Ur Ql |
|
|
|
|
|
Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipra; Imipramine metabolite; Norpramin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tofranil; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14794-2 |
Imipramine+Desipramine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Imipramine+Desipramine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14794-2 |
|
|
|
|
Both |
|
|
|
0 |
Imipramine+Desipr SerPl-sCnc |
|
|
|
Y |
|
Desi; Desip; Desipra; Desmethylimipramine; DRUG/TOXICOLOGY; Drugs; Imipra; Imipramine metabolite; Level; Norpramin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tofranil |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14795-9 |
Immunoglobulin light chains |
Imp |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Immunoglobulin light chains [Interpretation] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14795-9 |
|
|
|
|
Observation |
|
|
|
0 |
BJ Protein Ur-Imp |
|
|
|
|
|
Bence Jones protein; BJ Protein; BJP; Chain; Chemistry; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Impression; Impression/interpretation of study; Impressions; Imunoglbon; Imunoglobn; Interp; Interpretation; Nominal; Point in time; Random; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14796-7 |
Insulin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Insulin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
14796-7 |
|
|
|
|
Both |
|
|
|
0 |
Insulin SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Endocrine; Endocrinology; HUM; Humulin; IH7; Insul; Lente; Level; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
